Bilaketaren emaitzak - Tan, Daniel SW

Nucleolar localization of an isoform of the IGF-I precursor nork Tan, Daniel SW, Cook, Alexandra, Chew, Shern L

Testu osoa Testu osoa Testu osoa

“Anti-HBc alone” in human immunodeficiency virus-positive and immuno-suppressed lymphoma patients nork Koo, Yu Xuan, Tan, Daniel SW, Tan, Iain BH, Quek, Richard, Tao, Miriam, Lim, Soon Thye

Testu osoa Testu osoa Testu osoa

Overcoming the impact of the COVID‐19 pandemic on oncology early phase trials and drug development in Asia—Experiences and perspectives of the Asian Oncology Early Phase 1 Consorti... nork Shimizu, Toshio, Kim, Dong‐Wan, Loong, Herbert H., Lin, Chia‐Chi, Ng, Matthew CH, Yamamoto, Noboru, Ma, Brigette, Tan, Daniel SW

Testu osoa Testu osoa Testu osoa

Characterization of colibactin-associated mutational signature in an Asian oral squamous cell carcinoma and in other mucosal tumor types nork Boot, Arnoud, Ng, Alvin W.T., Chong, Fui Teen, Ho, Szu-Chi, Yu, Willie, Tan, Daniel S.W., Iyer, N. Gopalakrishna, Rozen, Steven G.

Testu osoa Testu osoa Testu osoa

Targeting Cancer Stem Cell Plasticity Through Modulation of Epidermal Growth Factor and Insulin-Like Growth Factor Receptor Signaling in Head and Neck Squamous Cell Cancer nork Leong, Hui Sun, Chong, Fui Teen, Sew, Pui Hoon, Lau, Dawn P., Wong, Bernice H., Teh, Bin-Tean, Tan, Daniel S.W., Iyer, N. Gopalakrishna

Testu osoa Testu osoa Testu osoa

Tongue carcinoma infrequently harbor common actionable genetic alterations nork Tan, Daniel SW, Wang, Weining, Leong, Hui Sun, Sew, Pui Hoon, Lau, Dawn P, Chong, Fui Teen, Krisna, Sai Sakktee, Lim, Tony KH, Iyer, N Gopalakrishna

Testu osoa Testu osoa Testu osoa

Progression-Free and Overall Survival in ALK-Positive NSCLC Patients Treated with Sequential Crizotinib and Ceritinib nork Gainor, Justin F., Tan, Daniel S.W., De Pas, Tomasso, Solomon, Benjamin J., Ahmad, Aziah, Lazzari, Chiara, de Marinis, Filippo, Spitaleri, Gianluca, Schultz, Katherine, Friboulet, Luc, Yeap, Beow Y., Engleman, Jeffrey A., Shaw, Alice T.

Testu osoa Testu osoa Testu osoa

Phase Ib Study of Combination Therapy with MEK Inhibitor Binimetinib and Phosphatidylinositol 3‐Kinase Inhibitor Buparlisib in Patients with Advanced Solid Tumors with RAS/RAF Alte... nork Bardia, Aditya, Gounder, Mrinal, Rodon, Jordi, Janku, Filip, Lolkema, Martijn P., Stephenson, Joe J., Bedard, Philippe L., Schuler, Martin, Sessa, Cristiana, LoRusso, Patricia, Thomas, Michael, Maacke, Heiko, Evans, Helen, Sun, Yongjian, Tan, Daniel S.W.

Testu osoa Testu osoa Testu osoa

Ceritinib Efficacy and Safety in Treatment-Naive Asian Patients With Advanced ALK-Rearranged NSCLC: An ASCEND-4 Subgroup Analysis nork Tan, Daniel S.W., Geater, Sarayut, Yu, Chong-Jen, Tsai, Chun-Ming, Hsia, Te-Chun, Chen, Jun, Lin, Meng-Chih, Lu, You, Sriuranpong, Virote, Yang, Cheng-Ta, Sen, Paramita, Branle, Fabrice, Shi, Michael, Wu, Yi-Long

Testu osoa Testu osoa Testu osoa

Microfluidic enrichment for the single cell analysis of circulating tumor cells nork Yeo, Trifanny, Tan, Swee Jin, Lim, Chew Leng, Lau, Dawn Ping Xi, Chua, Yong Wei, Krisna, Sai Sakktee, Iyer, Gopal, Tan, Gek San, Lim, Tony Kiat Hon, Tan, Daniel S.W., Lim, Wan-Teck, Lim, Chwee Teck

Testu osoa Testu osoa Testu osoa

Clinical Characteristics and Outcomes in Advanced KRAS-Mutated NSCLC: A Multicenter Collaboration in Asia (ATORG-005) nork Lee, Jiyun, Tan, Aaron C., Zhou, Siqin, Yoon, Shinkyo, Liu, Siyang, Masuda, Ken, Hayashi, Hidetoshi, Batra, Ullas, Kim, Dong-Wan, Goto, Yasushi, Tan, Sze Huey, Wu, Yi-Long, Lee, Dae Ho, Tan, Daniel S.W., Ahn, Myung-Ju

Testu osoa Testu osoa Testu osoa

Bosutinib inhibits migration and invasion via ack1 in kras mutant non-small cell lung cancer nork Tan, Daniel SW, Haaland, Benjamin, Gan, Jia Min, Tham, Su Chin, Sinha, Indrajit, Tan, Eng Huat, Lim, Kiat Hon, Takano, Angela, Krisna, Sai Sakktee, Thu, Minn Minn Myint, Liew, Hoe Peng, Ullrich, Axel, Lim, Wan-Teck, Chua, Boon Tin

Testu osoa Testu osoa Testu osoa

Long-Term Efficacy and Safety of Entrectinib in ROS1 Fusion–Positive NSCLC nork Drilon, Alexander, Chiu, Chao-Hua, Fan, Yun, Cho, Byoung Chul, Lu, Shun, Ahn, Myung-Ju, Krebs, Matthew G., Liu, Stephen V., John, Thomas, Otterson, Gregory A., Tan, Daniel S.W., Patil, Tejas, Dziadziuszko, Rafal, Massarelli, Erminia, Seto, Takashi, Doebele, Robert C., Pitcher, Bethany, Kurtsikidze, Nino, Heinzmann, Sebastian, Siena, Salvatore

Testu osoa Testu osoa Testu osoa

BM-32 CERITINIB (LDK378) FOR TREATMENT OF PATIENTS WITH ALK-REARRANGED (ALK+) NON-SMALL CELL LUNG CANCER (NSCLC) AND BRAIN METASTASES (BM) IN THE ASCEND-1 TRIAL nork Shaw, Alice, Mehra, Ranee, Tan, Daniel S.W., Felip, Enriqueta, Chow, Laura Q.M., Ross Camidge, D., Vansteenkiste, Johan, Sharma, Sunil, De Pas, Tommaso, Riely, Gregory J., Solomon, Benjamin J., Wolf, Juergen, Thomas, Michael, Schuler, Martin, Liu, Geoffrey, Santoro, Armando, Geraldes, Margarida, Sen, Paramita, Boral, Anthony J., Yovine, Alejandro, Kim, Dong-Wan

Testu osoa Testu osoa

Human Tumor-Infiltrating MAIT Cells Display Hallmarks of Bacterial Antigen Recognition in Colorectal Cancer nork Li, Shamin, Simoni, Yannick, Becht, Etienne, Loh, Chiew Yee, Li, Naisi, Lachance, Daniel, Koo, Si-Lin, Lim, Teck Por, Tan, Emile Kwong Wei, Mathew, Ronnie, Nguyen, Andrew, Golovato, Justin, Berkson, Julia D., Prlic, Martin, Lee, Bernett, Minot, Samuel S., Nagarajan, Niranjan, Dey, Neelendu, Tan, Daniel S.W., Tan, Iain B., Newell, Evan W.

Testu osoa Testu osoa Testu osoa

Ceritinib in ALK-Rearranged Non–Small-Cell Lung Cancer nork Shaw, Alice T., Kim, Dong-Wan, Mehra, Ranee, Tan, Daniel S.W., Felip, Enriqueta, Chow, Laura Q.M., Camidge, D. Ross, Vansteenkiste, Johan, Sharma, Sunil, De Pas, Tommaso, Riely, Gregory J., Solomon, Benjamin J., Wolf, Juergen, Thomas, Michael, Schuler, Martin, Liu, Geoffrey, Santoro, Armando, Lau, Yvonne Y., Goldwasser, Meredith, Boral, Anthony L., Engelman, Jeffrey A.

Testu osoa Testu osoa Testu osoa

Intracranial Efficacy of Selpercatinib in RET Fusion-Positive Non–Small Cell Lung Cancers on the LIBRETTO-001 Trial nork Subbiah, Vivek, Gainor, Justin F., Oxnard, Geoffrey R., Tan, Daniel S.W., Owen, Dwight H., Cho, Byoung Chul, Loong, Herbert H., McCoach, Caroline E., Weiss, Jared, Kim, Yu Jung, Bazhenova, Lyudmila, Park, Keunchil, Daga, Haruko, Besse, Benjamin, Gautschi, Oliver, Rolfo, Christian, Zhu, Edward Y., Kherani, Jennifer F., Huang, Xin, Kang, Suhyun, Drilon, Alexander

Testu osoa Testu osoa Testu osoa

Mutational landscapes of tongue carcinoma reveal recurrent mutations in genes of therapeutic and prognostic relevance nork Vettore, Andre Luiz, Ramnarayanan, Kalpana, Poore, Gregory, Lim, Kevin, Ong, Choon Kiat, Huang, Kie Kyon, Leong, Hui Sun, Chong, Fui Teen, Lim, Tony Kiat-Hon, Lim, Weng Khong, Cutcutache, Ioana, Mcpherson, John R., Suzuki, Yuka, Zhang, Shenli, Skanthakumar, Thakshayeni, Wang, Weining, Tan, Daniel SW, Cho, Byoung Chul, Teh, Bin Tean, Rozen, Steve, Tan, Patrick, Iyer, N. Gopalakrishna

Testu osoa Testu osoa Testu osoa

A three gene immunohistochemical panel serves as an adjunct to clinical staging of patients with head and neck cancer nork Ong, Chin-Ann J., Shannon, Nicholas B., Mueller, Stefan, Lek, Sze Min, Qiu, Xuan, Chong, Fui Teen, Li, Ke, Koh, Kelvin K.N., Tay, Gerald C.A., Skanthakumar, Thakshayeni, Hwang, Jacqueline S.G., Hon Lim, Tony Kiat, Ang, Mei Kim, Tan, Daniel S.W., Tan, Ngian-Chye, Tan, Hiang Khoon, Soo, Khee Chee, Iyer, N. Gopalakrishna

Testu osoa Testu osoa Testu osoa

Deficiency of the splicing factor RBM10 limits EGFR inhibitor response in EGFR-mutant lung cancer nork Nanjo, Shigeki, Wu, Wei, Karachaliou, Niki, Blakely, Collin M., Suzuki, Junji, Chou, Yu-Ting, Ali, Siraj M., Kerr, D. Lucas, Olivas, Victor R., Shue, Jonathan, Rotow, Julia, Mayekar, Manasi K., Haderk, Franziska, Chatterjee, Nilanjana, Urisman, Anatoly, Yeo, Jia Chi, Skanderup, Anders J., Tan, Aaron C., Tam, Wai Leong, Arrieta, Oscar, Hosomichi, Kazuyoshi, Nishiyama, Akihiro, Yano, Seiji, Kirichok, Yuriy, Tan, Daniel S.W., Rosell, Rafael, Okimoto, Ross A, Bivona, Trever G.

Testu osoa Testu osoa Testu osoa